NO20033290L - Pyrrolderivater for behandling av cytokinformidlede sykdommer - Google Patents
Pyrrolderivater for behandling av cytokinformidlede sykdommerInfo
- Publication number
- NO20033290L NO20033290L NO20033290A NO20033290A NO20033290L NO 20033290 L NO20033290 L NO 20033290L NO 20033290 A NO20033290 A NO 20033290A NO 20033290 A NO20033290 A NO 20033290A NO 20033290 L NO20033290 L NO 20033290L
- Authority
- NO
- Norway
- Prior art keywords
- cytokine
- treatment
- mediated diseases
- pyrrole derivatives
- pyrrole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001013817 | 2001-01-22 | ||
| US27500501P | 2001-03-12 | 2001-03-12 | |
| PCT/IB2002/000176 WO2002057264A1 (en) | 2001-01-22 | 2002-01-22 | Pyrrole derivates for treating cytokine mediated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20033290D0 NO20033290D0 (no) | 2003-07-21 |
| NO20033290L true NO20033290L (no) | 2003-09-11 |
Family
ID=26608097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033290A NO20033290L (no) | 2001-01-22 | 2003-07-21 | Pyrrolderivater for behandling av cytokinformidlede sykdommer |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1377577B1 (zh) |
| KR (1) | KR20030076619A (zh) |
| CN (1) | CN100371336C (zh) |
| AR (1) | AR032511A1 (zh) |
| AT (1) | ATE329915T1 (zh) |
| BR (1) | BR0206650A (zh) |
| CA (1) | CA2435692A1 (zh) |
| CZ (1) | CZ20031949A3 (zh) |
| DE (1) | DE60212357T2 (zh) |
| EG (1) | EG23054A (zh) |
| ES (1) | ES2266500T3 (zh) |
| HU (1) | HUP0302807A2 (zh) |
| IL (1) | IL156861A0 (zh) |
| MX (1) | MXPA03006515A (zh) |
| NO (1) | NO20033290L (zh) |
| NZ (1) | NZ527099A (zh) |
| PE (1) | PE20030197A1 (zh) |
| PL (1) | PL362896A1 (zh) |
| RU (1) | RU2003122364A (zh) |
| SK (1) | SK9282003A3 (zh) |
| WO (1) | WO2002057264A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003015781A1 (fr) * | 2001-08-15 | 2003-02-27 | Sankyo Company, Limited | Nouvelles compositions pharmaceutiques antidiabetiques |
| WO2004009592A1 (ja) * | 2002-07-19 | 2004-01-29 | Sankyo Company, Limited | 二環性不飽和３級アミン化合物 |
| DK1830869T3 (da) | 2004-12-24 | 2013-08-26 | Spinifex Pharm Pty Ltd | Fremgangsmåde til behandling eller profylakse |
| US20130131007A1 (en) | 2005-09-07 | 2013-05-23 | Bebaas, Inc. | Vitamin b12 compositions |
| JP5230595B2 (ja) | 2006-03-20 | 2013-07-10 | スピニフェクス ファーマシューティカルズ ピーティーワイ リミテッド | 炎症性疼痛の治療または予防の方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997005878A1 (en) * | 1995-08-10 | 1997-02-20 | Merck & Co., Inc. | 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| US5792778A (en) * | 1995-08-10 | 1998-08-11 | Merck & Co., Inc. | 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| US5837719A (en) * | 1995-08-10 | 1998-11-17 | Merck & Co., Inc. | 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| IL137365A0 (en) * | 1999-07-21 | 2001-07-24 | Sankyo Co | Heteroaryl-substituted pyrrole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
-
2002
- 2002-01-20 EG EG20020068A patent/EG23054A/xx active
- 2002-01-22 DE DE60212357T patent/DE60212357T2/de not_active Expired - Fee Related
- 2002-01-22 CA CA002435692A patent/CA2435692A1/en not_active Abandoned
- 2002-01-22 IL IL15686102A patent/IL156861A0/xx unknown
- 2002-01-22 HU HU0302807A patent/HUP0302807A2/hu unknown
- 2002-01-22 ES ES02732180T patent/ES2266500T3/es not_active Expired - Lifetime
- 2002-01-22 KR KR10-2003-7009619A patent/KR20030076619A/ko not_active Application Discontinuation
- 2002-01-22 NZ NZ527099A patent/NZ527099A/en unknown
- 2002-01-22 PE PE2002000046A patent/PE20030197A1/es not_active Application Discontinuation
- 2002-01-22 SK SK928-2003A patent/SK9282003A3/sk not_active Application Discontinuation
- 2002-01-22 CZ CZ20031949A patent/CZ20031949A3/cs unknown
- 2002-01-22 WO PCT/IB2002/000176 patent/WO2002057264A1/en active IP Right Grant
- 2002-01-22 BR BR0206650-5A patent/BR0206650A/pt not_active IP Right Cessation
- 2002-01-22 MX MXPA03006515A patent/MXPA03006515A/es unknown
- 2002-01-22 EP EP02732180A patent/EP1377577B1/en not_active Expired - Lifetime
- 2002-01-22 CN CNB028069781A patent/CN100371336C/zh not_active Expired - Fee Related
- 2002-01-22 RU RU2003122364/04A patent/RU2003122364A/ru unknown
- 2002-01-22 PL PL02362896A patent/PL362896A1/xx not_active Application Discontinuation
- 2002-01-22 AR ARP020100212A patent/AR032511A1/es unknown
- 2002-01-22 AT AT02732180T patent/ATE329915T1/de not_active IP Right Cessation
-
2003
- 2003-07-21 NO NO20033290A patent/NO20033290L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL362896A1 (en) | 2004-11-02 |
| WO2002057264A1 (en) | 2002-07-25 |
| MXPA03006515A (es) | 2003-10-15 |
| NZ527099A (en) | 2004-09-24 |
| EG23054A (en) | 2004-02-29 |
| CA2435692A1 (en) | 2002-07-25 |
| EP1377577A1 (en) | 2004-01-07 |
| DE60212357D1 (de) | 2006-07-27 |
| ES2266500T3 (es) | 2007-03-01 |
| KR20030076619A (ko) | 2003-09-26 |
| PE20030197A1 (es) | 2003-03-12 |
| ATE329915T1 (de) | 2006-07-15 |
| DE60212357T2 (de) | 2007-05-31 |
| RU2003122364A (ru) | 2005-03-27 |
| CZ20031949A3 (cs) | 2003-12-17 |
| IL156861A0 (en) | 2004-02-08 |
| HUP0302807A2 (hu) | 2003-12-29 |
| CN1553911A (zh) | 2004-12-08 |
| AR032511A1 (es) | 2003-11-12 |
| CN100371336C (zh) | 2008-02-27 |
| SK9282003A3 (en) | 2004-04-06 |
| BR0206650A (pt) | 2004-02-25 |
| NO20033290D0 (no) | 2003-07-21 |
| EP1377577B1 (en) | 2006-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20031442D0 (no) | Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer | |
| NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
| NO20031443D0 (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
| NO20043000L (no) | Et preparat for behandling av nevrocerebrovaskulaere sykdommer | |
| NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
| NO20012995L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
| NO20041882L (no) | Fremgangsmater for behandling av okulare neovaskulaere sykdommer. | |
| NO20013380D0 (no) | 2-aminobenzoksazinonderivater for behandling av fedme | |
| NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
| NO20014379D0 (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
| NO20033203L (no) | Terapeutiske heterocykliske forbindelser | |
| NO20031615D0 (no) | Pyrazol-derivater for behandling av virus-sykdommer | |
| NO20026008D0 (no) | Fremgangsmåte for behandling av cardiovaskul¶re sykdommer | |
| NO20022087L (no) | Fremgangsmåte for behandling av diabetes | |
| DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
| NO20013381D0 (no) | 2-oksybenzoksazinonderivater for behandling av fedme | |
| NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
| IS6917A (is) | Epóþílon afleiður til meðhöndlunar erfiðra æxla | |
| NO20033205D0 (no) | Terapeutiske kromanforbindelser | |
| NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
| NO20034123L (no) | Fremgangsmåte for behandling av brennstoff | |
| NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
| NO20024776L (no) | Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte | |
| NO20024777L (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte | |
| NO20035538D0 (no) | Fremgangsmåte for fremstilling av zaleplon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |